Evidence map›Paper›PMID 26475541›Full record

ArticleJournal of the American Academy of Dermatology2015

Validity of the Simple-Measure for Assessing Psoriasis Activity (S-MAPA) for objectively evaluating disease severity in patients with plaque psoriasis.

Zelma C Chiesa Fuxench, Kristina Callis Duffin, Michael Siegel, Abby S Van Voorhees, Joel M Gelfand

Abstract readLetterMulticenter StudyValidation Study
In one paragraph

Article in Journal of the American Academy of Dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment.Clinical reviews in allergy & immunology · 2018
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zelma C Chiesa FuxenchCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: zelma.chiesafuxench@uphs.upenn.edu.
Kristina Callis DuffinDepartment of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah.
Michael SiegelNational Psoriasis Foundation, Portland, Oregon.
Abby S Van VoorheesDepartments of Dermatology, Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Joel M GelfandDepartments of Dermatology, Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

Funding

Clinical Pharmacoepidemiology Training ProgramT32GM075766 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Sean Hennessy, Charles Edward Leonard · 2006 to 2026
$8.4M
Comparative Effectiveness of Biologics for PsoriasisRC1AR058204 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI GELFAND, JOEL M · 2009 to 2010
$1.0M
Psoriasis and the Risk of DiabetesK24AR064310 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI GELFAND, JOEL M · 2013 to 2017
$870k
NIAMS NIH HHS K24 AR064310NIAMS NIH HHS K24-AR064310 36NIAMS NIH HHS RC1 AR058204NIAMS NIH HHS RC1-AR058204NIGMS NIH HHS 5T32GM075766-09NIGMS NIH HHS T32 GM075766
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Quality of LifeSeverity of Illness IndexAdultFemaleHumansMaleMiddle AgedPsoriasisROC Curve

Identifiers

PMID26475541
PMCPMC4609315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.